相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HMG-CoA Reductase Inhibition Delays DNA Repair and Promotes Senescence After Tumor Irradiation
Elena V. Efimova et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Cerasomal Lovastatin Nanohybrids for Efficient Inhibition of Triple-Negative Breast Cancer Stem Cells To Improve Therapeutic Efficacy
Liujiang Song et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
US Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer
Harpreet Singh et al.
CLINICAL CANCER RESEARCH (2018)
Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy
Patricia M. R. Pereira et al.
NATURE COMMUNICATIONS (2018)
High Cholesterol/Low Cholesterol: Effects in Biological Membranes: A Review
Witold K. Subczynski et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2017)
Simvastatin and MBCD Inhibit Breast Cancer-Induced Osteoclast Activity by Targeting Osteoclastogenic Factors
Kaushik Chowdhury et al.
CANCER INVESTIGATION (2017)
Neratinib induces ErbB2 ubiquitylation and endocytic degradation via HSP90 dissociation in breast cancer cells
Yingqiu Zhang et al.
CANCER LETTERS (2016)
Candidate Antimetastasis Drugs Suppress the Metastatic Capacity of Breast Cancer Cells by Reducing Membrane Fluidity
Weina Zhao et al.
CANCER RESEARCH (2016)
Targeting HER2 for the Treatment of Breast Cancer
Mothaffar F. Rimawi et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Structural insights into functional lipid-protein interactions in secondary transporters
Caroline Koshy et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Flotillin depletion affects ErbB protein levels in different human breast cancer cells
Nagham Asp et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
A systematic review of dual targeting in HER2-positive breast cancer
Iben Kumler et al.
CANCER TREATMENT REVIEWS (2014)
Flotillins as regulators of ErbB2 levels in breast cancer
S. Pust et al.
ONCOGENE (2013)
Treatment of HER2-positive breast cancer: current status and future perspectives
Carlos L. Arteaga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Improving Treatment of HER2-Positive Cancers: Opportunities and Challenges
Howard M. Stern
SCIENCE TRANSLATIONAL MEDICINE (2012)
The ERBB network: at last, cancer therapy meets systems biology
Yosef Yarden et al.
NATURE REVIEWS CANCER (2012)
Simvastatin induces derepression of PTEN expression via NFκB to inhibit breast cancer cell growth
Nayana Ghosh-Choudhury et al.
CELLULAR SIGNALLING (2010)
Lipid Rafts As a Membrane-Organizing Principle
Daniel Lingwood et al.
SCIENCE (2010)
Effects of lovastatin on breast cancer cells: a proteo-metabonomic study
Jelena Klawitter et al.
BREAST CANCER RESEARCH (2010)
Cholesterol transport in steroid biosynthesis: Role of protein-protein interactions and implications in disease states
Malena B. Rone et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The role of membrane microdomains in transmembrane signaling through the epithelial glycoprotein Gp140/CDCP1
Stacy M. Alvares et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)
Cellular cholesterol trafficking and compartmentalization
Elina Ikonen
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
EGF-ERBB signalling: towards the systems level
Ami Citri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
A quantitative protein interaction network for the ErbB receptors using protein microarrays
RB Jones et al.
NATURE (2006)
Lipid segregation and IgE receptor signaling: A decade of progress
D Holowka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2005)
Role of cholesterol and lipid organization in disease
FR Maxfield et al.
NATURE (2005)
Effects of trace elements on membrane fluidity
JJ Garcia et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2005)
Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism
MA Shibata et al.
CARCINOGENESIS (2004)
Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2
P Nagy et al.
JOURNAL OF CELL SCIENCE (2002)
Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy
A Citri et al.
EMBO JOURNAL (2002)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
分享论文
